Ian Mortimer Xenon Pharmaceuticals Inc. (XENE) insider trading activity

XENE Quotes by TradingView

Ian Mortimer is PRESIDENT & CEO of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 31,302 shares of XENE, which is worth approximately $1.25 Million. The most recent transaction as insider was on May 24, 2023, when has been sold 31,655 shares (Common Shares) at a price of $41.43 per share, resulting in proceeds of $1,311,466. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.3K
0% 3M change
0% 12M change
Total Value Held $1.25 Million

IAN MORTIMER Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 24 2023
SELL
Open market or private sale
$1,311,466 $41.43 p/Share
31,655 Reduced 50.28%
31,302 Common Shares
May 24 2023
SELL
Payment of exercise price or tax liability
$518,104 $41.84 p/Share
12,383 Reduced 27.46%
32,709 Common Shares
May 24 2023
BUY
Exercise of conversion of derivative security
$673,291 $9.71 p/Share
69,340 Added 67.18%
33,880 Common Shares
IM

Ian Mortimer

PRESIDENT & CEO
Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XENE